TY - JOUR
T1 - Speech intelligibility in a speaker with idiopathic Parkinson's disease before and after treatment
AU - Cannito, Michael P.
AU - Suiter, Debra M.
AU - Chorna, Lesya
AU - Beverly, Dorian
AU - Wolf, Teresa
AU - Watkins, Jeremy
PY - 2008/12
Y1 - 2008/12
N2 - A speaker with hypokinetic dysarthria secondary to idiopathic Parkinson's disease (PD) was studied before and after Lee Silverman Voice Treatment (LSVT®) to evaluate treatment-related changes in intelligibility of connected speech. He presented with reduced loudness and a weak, breathy voice quality (in addition to monoloudness, monopitch, short phrases, and increased rate). Following treatment, a louder, less breathy voice quality was perceived. Sentence productions were recorded on each of 3 days before and after LSVT®. These were presented to five healthy listeners, under carefully psychoacoustically controlled conditions, with equalization of intensity of signal presentation of all utterances. Listeners typed what they thought the speaker said, and percent words correctly understood were calculated. Additionally, harmonic amplitude differences and rate of syllable production were also analyzed for each utterance. Results indicated a significant improvement in intelligibility following treatment (p <.01). Rate of articulatory production did not differ significantly from pre- to post-LSVT®; however, harmonic amplitudes (re: H1) increased significantly (p <.05) posttreatment as part of an overall upward redistribution of spectral energy. We propose that salience of formants due to increased harmonic energy, resulting from treatment-related phonatory changes, accounts in part for the improved intelligibility exhibited by this speaker following LSVT®.
AB - A speaker with hypokinetic dysarthria secondary to idiopathic Parkinson's disease (PD) was studied before and after Lee Silverman Voice Treatment (LSVT®) to evaluate treatment-related changes in intelligibility of connected speech. He presented with reduced loudness and a weak, breathy voice quality (in addition to monoloudness, monopitch, short phrases, and increased rate). Following treatment, a louder, less breathy voice quality was perceived. Sentence productions were recorded on each of 3 days before and after LSVT®. These were presented to five healthy listeners, under carefully psychoacoustically controlled conditions, with equalization of intensity of signal presentation of all utterances. Listeners typed what they thought the speaker said, and percent words correctly understood were calculated. Additionally, harmonic amplitude differences and rate of syllable production were also analyzed for each utterance. Results indicated a significant improvement in intelligibility following treatment (p <.01). Rate of articulatory production did not differ significantly from pre- to post-LSVT®; however, harmonic amplitudes (re: H1) increased significantly (p <.05) posttreatment as part of an overall upward redistribution of spectral energy. We propose that salience of formants due to increased harmonic energy, resulting from treatment-related phonatory changes, accounts in part for the improved intelligibility exhibited by this speaker following LSVT®.
UR - http://www.scopus.com/inward/record.url?scp=84865391049&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84865391049&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84865391049
SN - 1065-1438
VL - 16
SP - 207
EP - 212
JO - Journal of Medical Speech-Language Pathology
JF - Journal of Medical Speech-Language Pathology
IS - 4
ER -